OBJECTIVE
We hypothesized that the previously observed T1 effect of a small monocrystalline iron oxide preparation can be exploited to decrease T1 relaxation time of blood. Such a decrease, particularly if present for a long time, could be used to improve the quality of MR angiograms. To test the hypothesis, we performed phantom studies and in vivo animal experiments.
MATERIALS AND METHODS
The effect of the monocrystalline iron oxide preparation on the MR signal intensity (spoiled gradient-recalled acquisition in the steady state pulse sequences, various timing parameters) of human whole blood was first tested in a phantom (dose range of monocrystalline iron oxide preparation, 0-3 mumol Fe/ml). Subsequent experiments were performed in rats (n = 7) and in rabbits (n = 6) to determine whether predicted changes in signal intensity could be observed in vivo.
RESULTS
Dose optimization studies in rats indicate that injected doses of 15-50 mumol Fe/kg (0.8-2.8 mg Fe/kg) of monocrystalline iron oxide preparation resulted in threefold to fourfold increases of aortic signal-to-noise ratio. Because of its long plasma half-life (180 min in rats), the iron oxide preparation markedly improved the quality of images of the vasculature of the lungs, abdomen, and extremities.
CONCLUSION
Our experimental results suggest that this and possibly other iron oxide preparations are alternatives to compounds containing macromolecular gadolinium and could be useful for clinical MR angiography.
[1]
R. Brasch,et al.
Tumor angiography using high-resolution, three-dimensional magnetic resonance imaging: comparison of gadopentetate dimeglumine and a macromolecular blood-pool contrast agent.
,
1995,
Academic radiology.
[2]
Ralph Weissleder,et al.
Long-circulating iron oxides for MR imaging
,
1995
.
[3]
F Demsar,et al.
Angiographic properties of Gd-DTPA-24-cascade-polymer--a new macromolecular MR contrast agent.
,
1995,
European journal of radiology.
[4]
R. Aaslid,et al.
Transcranial color‐coded duplex sonography, magnetic resonance angiography, and computed tomography angiography: Methods, applications, advantages, and limitations
,
1995,
Journal of clinical ultrasound : JCU.
[5]
A. Olukotun,et al.
Phase I clinical evaluation of a new iron oxide MR contrast agent
,
1994,
Journal of magnetic resonance imaging : JMRI.
[6]
R. Weissleder,et al.
Delivery of virus-sized iron oxide particles to rodent CNS neurons.
,
1994,
Neurosurgery.
[7]
H. Bosmans,et al.
MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits.
,
1990,
AJR. American journal of roentgenology.